Chemokine (C-C Motif) Ligand 5 (CCL5) Peptide
CCL5
适用: 人, 小鼠
宿主: 合成
BP, WB
产品编号 ABIN974586
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Chemokine (C-C Motif) Ligand 5 (CCL5) Peptide (ABIN974586)
抗原
CCL5
(Chemokine (C-C Motif) Ligand 5 (CCL5))
宿主
人, 小鼠
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
-
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-CCL5 antibody (Catalog #: ARP37191_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
纯化方法
- Purified
-
-
Chemokine (C-C Motif) Ligand 5 (CCL5) (AA 24-91) peptide
CCL5 适用: 人 宿主: 大肠杆菌（E. Coli） SDS
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
浓度
- 1 mg/mL
-
缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CCL5 (Chemokine (C-C Motif) Ligand 5 (CCL5))
-
背景
-
Recently, it has been shown that genetic polymorphisms can result in diminished expression of CCL5, which results in increased susceptibility to and progression of infectious diseases. CCL5, together with Th cytokine mRNA expression, is temporally up-regulated during pneumococcal carriage. CCL5 is an essential factor for the induction and maintenance of protective pneumococcal immunity
Alias Symbols: SISd, Scya5, RANTES, TCP228, MuRante, MuRantes
Protein Interaction Partner: Ccr1
Protein Size: 91 -
分子量
- 10 kDa
-
基因ID
- 20304
-
NCBI登录号
- NM_013653, NP_038681
-
UniProt
- P30882
抗原
-
You are here:
